Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Boehringer Ingelheim and CarthroniX announce partnership to pursue small molecule therapeutics in canine oncology
Wednesday, June 15, 2022Boehringer Ingelheim a global leader in animal health and CarthroniX a biopharmaceutical company focused on developing small moleculebased therapies for degenerative and agingrelated diseases announce that they have entered into a research collaborat...
Evotec enters a drug discovery collaboration with Janssen
Wednesday, June 15, 2022Evotec SE announced today that the Company has entered a drug discovery collaboration with Janssen Pharmaceutica NV one of the Janssen Pharmaceutical Companies of Johnson Johnson Janssen Evotecs innovative TargetAlloMod platforms will be evaluated t...
FDA Approves Lilly and Incyte's OLUMIANT® (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata
Tuesday, June 14, 2022Eli Lilly and Company and Incyte announced today that the US Food and Drug Administration FDA has approved OLUMIANT baricitinib a oncedaily pill as a firstindisease systemic treatment for adults with severe alopecia areata AA available as mg mg and m...
Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47
Tuesday, June 14, 2022Pfizer Inc MorphoSys US Inc a fully owned subsidiary of MorphoSys AG FSE MOR NASDAQMOR and Incyte NASDAQINCY today announced a clinical trial collaboration and supply agreement to investigate the immunotherapeutic combination of Pfizers TTI a novel S...
ImmunoGen Announces Research Collaboration with Oxford BioTherapeutics to Develop Novel Antibody-Drug Conjugates
Monday, June 13, 2022ImmunoGen Inc a leader in the expanding field of antibodydrug conjugates ADCs for the treatment of cancer today announced a multiyear collaboration to research novel firstinclass ADCs with Oxford BioTherapeutics OBT a clinical stage oncology company...
Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA™ for the Treatment of ALS
Monday, June 13, 2022Amylyx Pharmaceuticals Inc today announced that Health Canada has approved ALBRIOZA sodium phenylbutyrate and ursodoxicoltaurine with conditions for the treatment of amyotrophic lateral sclerosis ALS Clinical data demonstrated a statistically signifi...
U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)
Friday, June 10, 2022Roche today announced that the United States Food and Drug Administration US FDA has approved Foundation Medicines FoundationOneCDx as a companion diagnostic CDx for Roches Rozlytrek entrectinib FoundationOne CDx is a comprehensive genomic profiling...
Ferring Announces New Collaboration for Development of Olamkicept
Friday, June 10, 2022Ferring Pharmaceuticals today announced it has entered into a strategic collaboration with IMab to further develop olamkicept in inflammatory bowel disease IBD and related inflammatory conditions Olamkicept is the first and only clinical stage selec...
Opiant Pharmaceuticals and Aptar Pharma Expand Long-Term Collaboration for the Manufacture of Unidose Nasal Spray for OPNT003, Nasal Nalmefene
Thursday, June 09, 2022Opiant Pharmaceuticals Inc today announced a capacity investment agreement with Aptar Pharma Aptar a leading provider of drug delivery systems to expand production of Aptars nasal Unidose device which will be used in the production of commercial supp...
Integral Molecular and Optimeos Life Sciences Enter Partnership to Develop mRNA and DNA-Based Gene Therapies Using Molecular Targeting
Thursday, June 09, 2022Integral Molecular and Optimeos Life Sciences announce a partnership to develop nextgeneration mRNA and DNA therapeutics that will use antibodybased molecular targeting to direct vaccines and gene therapies to relevant tissues in a patients body
